The carbohydrate-deficient glycoprotein syndromes are a recently delin
eated group of genetic, multisystemic diseases with major nervous syst
em involvement. Three distinct variants have been recognized and there
are probably many more. They are characterized by a deficiency of the
carbohydrate moiety of secretory glycoproteins, lysosomal enzymes and
probably also membranous glycoproteins. The biochemical changes are m
ost readily observed in serum transferrin and the diagnosis is usually
made by isoelectric focusing of this glycoprotein. The deficiency of
sialic acid, in particular, results in a cathodal shift and hence the
presence of abnormal isoforms of transferrin with higher isoelectric p
oints than normal. The basic defects are probably in the processing an
d synthesis of the carbohydrate moiety of glycoproteins; there is indi
rect evidence for a deficiency of asparagine-N-linked oligosaccharide
transfer in type I (endoplasmic reticulum defect) and for a deficiency
of N-acetylglucosaminyltransferase II in type II (Golgi defect). From
the large number of patients detected in only a few years, it is expe
cted that these diseases will become as important as, for example, the
lysosomal, peroxisomal or mitochondrial disorders. Their study will u
ndoubtedly yield a wealth of new information on the function of glycop
roteins and of their carbohydrate moiety.